Leerink Partners analyst Puneet Souda maintained a Buy rating on Agilent (A – Research Report) on January 7 and set a price target of $175.00. The company's shares closed last Wednesday at $140.43. According to TipRanks.com, Souda 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -3.6% and a 37.3% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience. Currently, the analyst consensus on Agilent is a Strong Buy with an average price target of $179.00.
https://www.tipranks.com/news/blurbs/leerink-partners-maintains-a-buy-rating-on-agilent-a?utm_source=advfn.com&utm_medium=referral
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Ago 2022 até Set 2022 Click aqui para mais gráficos Agilent Technologies.
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Set 2021 até Set 2022 Click aqui para mais gráficos Agilent Technologies.